Search the web
Welcome, Guest
[Sign Out, My Account]

Sunday, April 20 2014 4:57pm ET - U.S. Markets Closed.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Diagnostic Substances
Composite Value: 1033.7
Today's Change: -0.23%
S&P 500: 0.00%
chart for
[Diagnostic Substances (^YHOh789)]
Diagnostic Substances News
Federal Court Grants Preliminary Approval Of Settlement In Abaxis Shareholder Lawsuit
Fri Apr 18 (PR Newswire)
UNION CITY, Calif., April 18, 2014 /PRNewswire/ -- On April 15, 2014, the United States District Court for the Northern District of California, granted preliminary approval of a settlement that Abaxis, Inc. has reached with Plaintiff St. Louis Police Retirement System ("Plaintiff") in a shareholder class and derivative action that Plaintiff filed on October 1, 2012 on behalf of itself and all others similarly situated, and derivatively on behalf of Abaxis ("Abaxis" or the "Company"), and against certain of Abaxis's officers and directors (the "Defendants"), entitled St. Louis Police Retirement System v. Severson, et al., Case No. 12-cv-05086-YGR (N.D. Cal.) (the "Action"). The Court's order granting preliminary approval of the settlement requires Abaxis to provide notice to its stockholders of the information about the Action contained in this press release. The Action alleges, among other things, that the Abaxis proxy statement in connection with the Company's 2012 annual meeting of stockholders contained materially false and misleading statements concerning a proposed amendment to the Company's 2005 Equity Incentive Plan and that Defendants granted and/or received Abaxis restricted stock units in excess of the so-called Full Value Award limit under the Company's 2005 Equity Incentive Plan.
Trinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results - (GlobeNewswire)
Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014 - (Marketwire)
More News on Diagnostic Substances: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
Atossa Genetics Inc. [ATOS] 0.00% $31.8 M
ImmuCell Corporation [ICCC] 0.00% $13.8 M
Meridian Bioscience Inc. [VIVO] 0.00% $906.6 M
ABAXIS, Inc. [ABAX] 0.00% $871.4 M
SurModics, Inc. [SRDX] 0.00% $308.2 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
IDEXX Laboratories, Inc. [IDXX] 0.00% $6.1 B
Neogen Corporation [NEOG] 0.00% $1.5 B
Meridian Bioscience Inc. [VIVO] 0.00% $906.6 M
ABAXIS, Inc. [ABAX] 0.00% $871.4 M
Quidel Corporation [QDEL] 0.00% $830.1 M
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
04/23/14 QDEL Quidel Corporation Earnings Conference Call (Q1 2014)
04/24/14 ABAX ABAXIS INC Q4 2014 Earnings Release
04/24/14 VIVO Meridian Bioscience, Inc. Q2 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
03/28/14 APPY Venaxis, Inc. upside earnings surprise (+6.67%)
03/27/14 ATOS Atossa Genetics Inc. upside earnings surprise (+21.05%)
03/14/14 NYMX Nymox Pharmaceutical Corporatio upside earnings surprise (+33.33%)
More Recent Events...
Sponsor Results
Forward provides continuous passive motion therapy equipment
Medical Equipment & Parts
Need Specialty Medical, Hospital and Healthcare Equipment & Parts?
Medical Equip Training
Employee training system for DME and HME companies.
(What's This?)
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:12B
Price / Earnings:59.0
Price / Book:40.5
Net Profit Margin (mrq):7.3%
Price To Free Cash Flow (mrq):271.2
Return on Equity:7.8%
Total Debt / Equity:60.2
Dividend Yield:1.7%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?